| |
| | TB Policies: Treatment (Site not responding. Last check: 2007-09-12) |
 | | An immunocompromised individual, or one who is at risk for immunocompromise, should be evaluated every six (6) months after the completion of a full course of anti- tuberculosis treatment for two (2) years. |
 | | If a pregnant woman is immunocompromised, or is at risk for immunocompromise, she should be evaluated every six (6) months after the completion of a full course of anti-tuberculosis treatment for two (2) years. |
 | | Isoniazid and rifampin (or isoniazid, rifampin, and ethambutol if susceptibility results are unavailable) should be given for at least nine (9) months, and for at least six (6) months beyond documented culture conversion, whichever is longer. |
| www.cpmc.columbia.edu /tbcpp/vi-tx.html (9759 words) |
|